
Global Viral Vectors Market Research Report 2025(Status and Outlook)
Description
Report Overview
Viral vectors are engineered viruses used to deliver genetic material into cells for therapeutic or research purposes, leveraging the natural ability of viruses to infect cells and transfer genetic information. Key types include adenoviral, lentiviral, adeno-associated viral (AAV), and retroviral vectors, each offering distinct advantages in terms of transduction efficiency, cargo capacity, immunogenicity, and persistence of gene expression. The market for viral vectors is driven by the rapid growth of gene therapy and cell therapy applications, particularly in treating genetic disorders, cancers, and rare diseases, as well as their use in vaccine development (e.g., COVID-19 vaccines employing adenoviral vectors). Increasing investments in biopharmaceutical R&D, advancements in vector engineering to enhance safety and efficacy, and regulatory approvals for gene therapies (such as Luxturna and Zolgensma) further propel market expansion. However, challenges include high manufacturing costs, scalability issues, and potential immune responses. Geographically, North America and Europe dominate due to strong biotech infrastructure and funding, while Asia-Pacific shows significant growth potential with rising clinical trials and government support for gene therapy development. Key players include Thermo Fisher Scientific, Merck KGaA, Lonza, and Charles River Laboratories, among others, competing through innovation in vector design, production efficiency, and strategic partnerships. The market is expected to grow robustly, supported by increasing demand for personalized medicine and expanding applications in CRISPR-based gene editing and regenerative medicine.
The global Viral Vectors market size was estimated at USD 1051.41 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Viral Vectors market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Viral Vectors market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Viral Vectors market.
Global Viral Vectors Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Market Segmentation (by Type)
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others
Market Segmentation (by Application)
Cancers
Inherited Disorders
Viral Infections
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Viral Vectors Market
Overview of the regional outlook of the Viral Vectors Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vectors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Viral Vectors, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Viral vectors are engineered viruses used to deliver genetic material into cells for therapeutic or research purposes, leveraging the natural ability of viruses to infect cells and transfer genetic information. Key types include adenoviral, lentiviral, adeno-associated viral (AAV), and retroviral vectors, each offering distinct advantages in terms of transduction efficiency, cargo capacity, immunogenicity, and persistence of gene expression. The market for viral vectors is driven by the rapid growth of gene therapy and cell therapy applications, particularly in treating genetic disorders, cancers, and rare diseases, as well as their use in vaccine development (e.g., COVID-19 vaccines employing adenoviral vectors). Increasing investments in biopharmaceutical R&D, advancements in vector engineering to enhance safety and efficacy, and regulatory approvals for gene therapies (such as Luxturna and Zolgensma) further propel market expansion. However, challenges include high manufacturing costs, scalability issues, and potential immune responses. Geographically, North America and Europe dominate due to strong biotech infrastructure and funding, while Asia-Pacific shows significant growth potential with rising clinical trials and government support for gene therapy development. Key players include Thermo Fisher Scientific, Merck KGaA, Lonza, and Charles River Laboratories, among others, competing through innovation in vector design, production efficiency, and strategic partnerships. The market is expected to grow robustly, supported by increasing demand for personalized medicine and expanding applications in CRISPR-based gene editing and regenerative medicine.
The global Viral Vectors market size was estimated at USD 1051.41 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Viral Vectors market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Viral Vectors market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Viral Vectors market.
Global Viral Vectors Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Market Segmentation (by Type)
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others
Market Segmentation (by Application)
Cancers
Inherited Disorders
Viral Infections
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Viral Vectors Market
Overview of the regional outlook of the Viral Vectors Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vectors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Viral Vectors, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
156 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Viral Vectors
- 1.2 Key Market Segments
- 1.2.1 Viral Vectors Segment by Type
- 1.2.2 Viral Vectors Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Viral Vectors Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Viral Vectors Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Viral Vectors Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Viral Vectors Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Viral Vectors Product Life Cycle
- 3.3 Global Viral Vectors Sales by Manufacturers (2020-2025)
- 3.4 Global Viral Vectors Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Viral Vectors Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Viral Vectors Market Competitive Situation and Trends
- 3.8.1 Viral Vectors Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Viral Vectors Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Viral Vectors Industry Chain Analysis
- 4.1 Viral Vectors Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Viral Vectors Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Viral Vectors Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Viral Vectors Market
- 5.7 ESG Ratings of Leading Companies
- 6 Viral Vectors Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Viral Vectors Sales Market Share by Type (2020-2025)
- 6.3 Global Viral Vectors Market Size Market Share by Type (2020-2025)
- 6.4 Global Viral Vectors Price by Type (2020-2025)
- 7 Viral Vectors Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Viral Vectors Market Sales by Application (2020-2025)
- 7.3 Global Viral Vectors Market Size (M USD) by Application (2020-2025)
- 7.4 Global Viral Vectors Sales Growth Rate by Application (2020-2025)
- 8 Viral Vectors Market Sales by Region
- 8.1 Global Viral Vectors Sales by Region
- 8.1.1 Global Viral Vectors Sales by Region
- 8.1.2 Global Viral Vectors Sales Market Share by Region
- 8.2 Global Viral Vectors Market Size by Region
- 8.2.1 Global Viral Vectors Market Size by Region
- 8.2.2 Global Viral Vectors Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Viral Vectors Sales by Country
- 8.3.2 North America Viral Vectors Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Viral Vectors Sales by Country
- 8.4.2 Europe Viral Vectors Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Viral Vectors Sales by Region
- 8.5.2 Asia Pacific Viral Vectors Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Viral Vectors Sales by Country
- 8.6.2 South America Viral Vectors Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Viral Vectors Sales by Region
- 8.7.2 Middle East and Africa Viral Vectors Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Viral Vectors Market Production by Region
- 9.1 Global Production of Viral Vectors by Region(2020-2025)
- 9.2 Global Viral Vectors Revenue Market Share by Region (2020-2025)
- 9.3 Global Viral Vectors Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Viral Vectors Production
- 9.4.1 North America Viral Vectors Production Growth Rate (2020-2025)
- 9.4.2 North America Viral Vectors Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Viral Vectors Production
- 9.5.1 Europe Viral Vectors Production Growth Rate (2020-2025)
- 9.5.2 Europe Viral Vectors Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Viral Vectors Production (2020-2025)
- 9.6.1 Japan Viral Vectors Production Growth Rate (2020-2025)
- 9.6.2 Japan Viral Vectors Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Viral Vectors Production (2020-2025)
- 9.7.1 China Viral Vectors Production Growth Rate (2020-2025)
- 9.7.2 China Viral Vectors Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 BioReliance
- 10.1.1 BioReliance Basic Information
- 10.1.2 BioReliance Viral Vectors Product Overview
- 10.1.3 BioReliance Viral Vectors Product Market Performance
- 10.1.4 BioReliance Business Overview
- 10.1.5 BioReliance SWOT Analysis
- 10.1.6 BioReliance Recent Developments
- 10.2 Cobra Biologics
- 10.2.1 Cobra Biologics Basic Information
- 10.2.2 Cobra Biologics Viral Vectors Product Overview
- 10.2.3 Cobra Biologics Viral Vectors Product Market Performance
- 10.2.4 Cobra Biologics Business Overview
- 10.2.5 Cobra Biologics SWOT Analysis
- 10.2.6 Cobra Biologics Recent Developments
- 10.3 Oxford BioMedica
- 10.3.1 Oxford BioMedica Basic Information
- 10.3.2 Oxford BioMedica Viral Vectors Product Overview
- 10.3.3 Oxford BioMedica Viral Vectors Product Market Performance
- 10.3.4 Oxford BioMedica Business Overview
- 10.3.5 Oxford BioMedica SWOT Analysis
- 10.3.6 Oxford BioMedica Recent Developments
- 10.4 UniQure
- 10.4.1 UniQure Basic Information
- 10.4.2 UniQure Viral Vectors Product Overview
- 10.4.3 UniQure Viral Vectors Product Market Performance
- 10.4.4 UniQure Business Overview
- 10.4.5 UniQure Recent Developments
- 10.5 FinVector
- 10.5.1 FinVector Basic Information
- 10.5.2 FinVector Viral Vectors Product Overview
- 10.5.3 FinVector Viral Vectors Product Market Performance
- 10.5.4 FinVector Business Overview
- 10.5.5 FinVector Recent Developments
- 10.6 MolMed
- 10.6.1 MolMed Basic Information
- 10.6.2 MolMed Viral Vectors Product Overview
- 10.6.3 MolMed Viral Vectors Product Market Performance
- 10.6.4 MolMed Business Overview
- 10.6.5 MolMed Recent Developments
- 10.7 MassBiologics
- 10.7.1 MassBiologics Basic Information
- 10.7.2 MassBiologics Viral Vectors Product Overview
- 10.7.3 MassBiologics Viral Vectors Product Market Performance
- 10.7.4 MassBiologics Business Overview
- 10.7.5 MassBiologics Recent Developments
- 10.8 Richter-Helm
- 10.8.1 Richter-Helm Basic Information
- 10.8.2 Richter-Helm Viral Vectors Product Overview
- 10.8.3 Richter-Helm Viral Vectors Product Market Performance
- 10.8.4 Richter-Helm Business Overview
- 10.8.5 Richter-Helm Recent Developments
- 10.9 FUJIFILM Diosynth Biotechnologies
- 10.9.1 FUJIFILM Diosynth Biotechnologies Basic Information
- 10.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors Product Overview
- 10.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Product Market Performance
- 10.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
- 10.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 10.10 Lonza
- 10.10.1 Lonza Basic Information
- 10.10.2 Lonza Viral Vectors Product Overview
- 10.10.3 Lonza Viral Vectors Product Market Performance
- 10.10.4 Lonza Business Overview
- 10.10.5 Lonza Recent Developments
- 10.11 Aldevron
- 10.11.1 Aldevron Basic Information
- 10.11.2 Aldevron Viral Vectors Product Overview
- 10.11.3 Aldevron Viral Vectors Product Market Performance
- 10.11.4 Aldevron Business Overview
- 10.11.5 Aldevron Recent Developments
- 10.12 Eurogentec
- 10.12.1 Eurogentec Basic Information
- 10.12.2 Eurogentec Viral Vectors Product Overview
- 10.12.3 Eurogentec Viral Vectors Product Market Performance
- 10.12.4 Eurogentec Business Overview
- 10.12.5 Eurogentec Recent Developments
- 10.13 Cell and Gene Therapy Catapult
- 10.13.1 Cell and Gene Therapy Catapult Basic Information
- 10.13.2 Cell and Gene Therapy Catapult Viral Vectors Product Overview
- 10.13.3 Cell and Gene Therapy Catapult Viral Vectors Product Market Performance
- 10.13.4 Cell and Gene Therapy Catapult Business Overview
- 10.13.5 Cell and Gene Therapy Catapult Recent Developments
- 10.14 Biovian
- 10.14.1 Biovian Basic Information
- 10.14.2 Biovian Viral Vectors Product Overview
- 10.14.3 Biovian Viral Vectors Product Market Performance
- 10.14.4 Biovian Business Overview
- 10.14.5 Biovian Recent Developments
- 10.15 Thermo Fisher Scientific (Brammer Bio)
- 10.15.1 Thermo Fisher Scientific (Brammer Bio) Basic Information
- 10.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product Overview
- 10.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product Market Performance
- 10.15.4 Thermo Fisher Scientific (Brammer Bio) Business Overview
- 10.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
- 10.16 VGXI
- 10.16.1 VGXI Basic Information
- 10.16.2 VGXI Viral Vectors Product Overview
- 10.16.3 VGXI Viral Vectors Product Market Performance
- 10.16.4 VGXI Business Overview
- 10.16.5 VGXI Recent Developments
- 10.17 PlasmidFactory
- 10.17.1 PlasmidFactory Basic Information
- 10.17.2 PlasmidFactory Viral Vectors Product Overview
- 10.17.3 PlasmidFactory Viral Vectors Product Market Performance
- 10.17.4 PlasmidFactory Business Overview
- 10.17.5 PlasmidFactory Recent Developments
- 11 Viral Vectors Market Forecast by Region
- 11.1 Global Viral Vectors Market Size Forecast
- 11.2 Global Viral Vectors Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Viral Vectors Market Size Forecast by Country
- 11.2.3 Asia Pacific Viral Vectors Market Size Forecast by Region
- 11.2.4 South America Viral Vectors Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Viral Vectors by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Viral Vectors Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Viral Vectors by Type (2026-2033)
- 12.1.2 Global Viral Vectors Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Viral Vectors by Type (2026-2033)
- 12.2 Global Viral Vectors Market Forecast by Application (2026-2033)
- 12.2.1 Global Viral Vectors Sales (K Units) Forecast by Application
- 12.2.2 Global Viral Vectors Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.